HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jesús Prieto Selected Research

Heme (Haem)

10/2016Phase I open label liver-directed gene therapy clinical trial for acute intermittent porphyria.
1/2012Renal failure affects the enzymatic activities of the three first steps in hepatic heme biosynthesis in the acute intermittent porphyria mouse.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jesús Prieto Research Topics

Disease

59Neoplasms (Cancer)
01/2022 - 01/2002
32Infections
12/2018 - 01/2002
29Hepatocellular Carcinoma (Hepatoma)
09/2017 - 05/2004
14Liver Cirrhosis (Hepatic Cirrhosis)
01/2019 - 04/2003
13Liver Diseases (Liver Disease)
10/2015 - 06/2002
12Inflammation (Inflammations)
09/2017 - 09/2006
11Fibrosis (Cirrhosis)
02/2016 - 03/2002
8Carcinoma (Carcinomatosis)
08/2012 - 06/2002
7Acute Intermittent Porphyria (Porphyria, Acute)
12/2022 - 03/2010
7Chronic Hepatitis C
01/2015 - 07/2003
7Hepatitis
08/2012 - 07/2003
6Biliary Liver Cirrhosis (Primary Biliary Cirrhosis)
01/2021 - 10/2005
6Virus Diseases (Viral Diseases)
10/2016 - 11/2002
6Liver Neoplasms (Liver Cancer)
11/2011 - 01/2007
4Acute Liver Failure (Fulminant Hepatic Failure)
04/2014 - 08/2006
3Fatty Liver
10/2017 - 04/2006
3Chronic Hepatitis (Chronic Active Hepatitis)
01/2016 - 07/2003
3Chronic Hepatitis B
08/2012 - 11/2002
3Carcinogenesis
01/2012 - 07/2008
2Portal Hypertension
10/2017 - 01/2013
2Insulin Resistance
02/2016 - 08/2011
2Colorectal Neoplasms (Colorectal Cancer)
01/2014 - 08/2005
2Neoplasm Metastasis (Metastasis)
01/2014 - 07/2011
2Obesity
08/2011 - 04/2010
2Wilms Tumor (Wilm's Tumor)
02/2009 - 07/2003
2Persistent Infection
01/2008 - 10/2003

Drug/Important Bio-Agent (IBA)

18Proteins (Proteins, Gene)FDA Link
01/2022 - 01/2002
15AntigensIBA
01/2022 - 05/2002
13Antiviral Agents (Antivirals)IBA
12/2018 - 11/2002
13Interleukin-12 (IL 12)IBA
01/2016 - 03/2002
12Peptides (Polypeptides)IBA
01/2018 - 10/2002
9CytokinesIBA
12/2009 - 11/2002
7Hydroxymethylbilane Synthase (Porphobilinogen Deaminase)IBA
12/2022 - 03/2010
7Protein Isoforms (Isoforms)IBA
01/2022 - 12/2005
6EpitopesIBA
09/2017 - 01/2002
6VaccinesIBA
10/2015 - 10/2002
6Messenger RNA (mRNA)IBA
10/2013 - 03/2002
6Monoclonal AntibodiesIBA
02/2009 - 06/2002
5DNA (Deoxyribonucleic Acid)IBA
12/2018 - 07/2008
5AntibodiesIBA
09/2017 - 07/2006
5Insulin-Like Growth Factor I (IGF-1)IBA
01/2016 - 03/2002
5Interferon-alpha (Interferon Alfa)IBA
08/2015 - 11/2002
5Transforming Growth Factor beta (TGF-beta)IBA
01/2014 - 09/2005
5AmphiregulinIBA
01/2012 - 05/2005
5Neoplasm Antigens (Tumor Antigens)IBA
05/2011 - 01/2002
4Recombinant ProteinsIBA
12/2022 - 01/2007
4Interleukin-6 (Interleukin 6)IBA
01/2017 - 02/2008
4LigandsIBA
08/2012 - 06/2006
4ErbB Receptors (EGF Receptor)IBA
01/2012 - 10/2008
4ChemokinesIBA
03/2011 - 01/2003
4Carcinoembryonic AntigenIBA
04/2004 - 01/2002
3Chloride-Bicarbonate AntiportersIBA
01/2021 - 08/2012
3ChromatinIBA
01/2017 - 03/2010
3RNA (Ribonucleic Acid)IBA
08/2015 - 02/2006
3Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
03/2015 - 06/2006
3MelatoninIBA
04/2014 - 01/2011
3Poly I-CIBA
08/2012 - 12/2009
3S-Adenosylmethionine (Ademetionine)IBA
06/2012 - 04/2006
3Therapeutic UsesIBA
01/2011 - 11/2005
3Thymidine KinaseIBA
07/2006 - 01/2002
2Hepatocyte Nuclear Factor 4IBA
10/2017 - 07/2003
2Pharmaceutical PreparationsIBA
09/2017 - 07/2011
2Heme (Haem)IBA
10/2016 - 01/2012
2PorphobilinogenIBA
10/2016 - 01/2012
2Hormones (Hormone)IBA
02/2016 - 10/2005
2Carbon Tetrachloride (Tetrachloromethane)IBA
01/2016 - 03/2010
2Bile Acids and Salts (Bile Acids)IBA
10/2015 - 02/2008
2Ursodeoxycholic Acid (Urso)FDA LinkGeneric
10/2015 - 02/2008
2Apolipoprotein A-I (Apolipoprotein A1)IBA
08/2015 - 07/2011
2Insulin (Novolin)FDA Link
03/2015 - 05/2014
2Thioacetamide (Thioacetamid)IBA
03/2015 - 03/2010
2Metalloproteases (Metalloproteinases)IBA
10/2014 - 03/2010
2Endoplasmic Reticulum Chaperone BiPIBA
02/2014 - 10/2013
2glucose-regulated proteinsIBA
02/2014 - 10/2013
2CholesterolIBA
01/2014 - 07/2008
2CD40 Ligand (CD40L)IBA
12/2013 - 08/2006
2Protein Subunit VaccinesIBA
12/2013 - 07/2008
2OvalbuminIBA
12/2013 - 09/2003
2EnzymesIBA
10/2013 - 01/2007
2Methionine (L-Methionine)FDA Link
10/2012 - 11/2004
2Viral AntigensIBA
08/2012 - 04/2007
2Methionine AdenosyltransferaseIBA
06/2012 - 09/2011
2PorphyrinsIBA
01/2012 - 03/2010
2Glucose (Dextrose)FDA LinkGeneric
09/2011 - 08/2011
2Interleukin-10 (Interleukin 10)IBA
01/2011 - 12/2007
2Bicarbonates (Hydrogen Carbonate)IBA
01/2011 - 02/2008
2Pemetrexed (MTA)FDA Link
12/2010 - 04/2008
2Transaminases (Aminotransferases)IBA
08/2010 - 12/2006
2RNA Precursors (Precursor, mRNA)IBA
07/2010 - 11/2009
2NF-kappa B (NF-kB)IBA
04/2010 - 11/2005
2OccludinIBA
08/2009 - 10/2008
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
12/2007 - 06/2005

Therapy/Procedure

35Therapeutics
01/2018 - 01/2002
9Immunotherapy
12/2015 - 10/2002
8Liver Transplantation
01/2019 - 06/2002
4Intravenous Injections
10/2016 - 12/2007
3Injections
12/2009 - 08/2005
2Aftercare (After-Treatment)
10/2016 - 11/2005
2Ligation
03/2015 - 01/2013
2Drug Therapy (Chemotherapy)
02/2009 - 07/2008